Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Centene Corp. | 15 | 0 | 5 | 0 | €69.30 | €82.57 | 19.149% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.10 | €100.00 | 20.337% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Stryker Corp. | 23 | 0 | 9 | 0 | €305.20 | €335.03 | 9.773% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.18 | €80.00 | 13.993% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.65 | €4.63 | 26.838% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.00 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.29 | €2.78 | 115.783% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.36 | €3.75 | 59.236% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €15.09 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.80 | €35.43 | 55.392% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €61.50 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €307.00 | - | - |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €71.48 | €100.00 | 39.899% |
| SCYNEXIS Inc. | 5 | 0 | 1 | 0 | €1.66 | €3.00 | 80.723% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.61 | €5.34 | 231.017% |